Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

Elise van Mulligen

doi:10.1016/S2665-9913(24)00038-9

Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

Elise van Mulligen^*

^*Corresponding author for this work

Rheumatology

Leiden University Medical Centre

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Scopus)

21 Downloads (Pure)

Original language	English
Pages (from-to)	e254-e255
Journal	The Lancet Rheumatology
Volume	6
Issue number	5
DOIs	https://doi.org/10.1016/S2665-9913(24)00038-9
Publication status	Published - May 2024

Access to Document

10.1016/S2665-9913(24)00038-9

Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritisFinal published version, 60 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{dc556f6b989545aeaba95f5a24e39818,

title = "Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis",

author = "\{van Mulligen\}, Elise",

year = "2024",

month = may,

doi = "10.1016/S2665-9913(24)00038-9",

language = "English",

volume = "6",

pages = "e254--e255",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

AU - van Mulligen, Elise

PY - 2024/5

Y1 - 2024/5

UR - https://www.scopus.com/pages/publications/85189464199

U2 - 10.1016/S2665-9913(24)00038-9

DO - 10.1016/S2665-9913(24)00038-9

M3 - Comment/Letter to the editor

C2 - 38583451

AN - SCOPUS:85189464199

SN - 2665-9913

VL - 6

SP - e254-e255

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 5

ER -

Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

Access to Document

Other files and links

Cite this